Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fried

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Kidney International|February 28, 2009
Creatinine and cystatin C: what are the values?Linda F Fried
Kidney International|June 6, 2008
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney diseaseLinda F Fried
Chemotherapy|January 1, 1977
Elimination of para-aminosalicylic acid in patients with liver disease and renal insufficiencyH Held, F Fried
Nephron|July 5, 2018
Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?Srijan Tandukar, Linda F Fried
Clinical Journal of the American Society of Nephrology : CJASN|April 19, 2015
Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con ViewLinda F Fried, Julia Lewis
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 3, 2026
Approach to Hyperkalemia: The Role of Diet and Pharmacological TherapiesAnnabel Biruete, Linda F Fried
Advances in Chronic Kidney Disease|October 24, 2012
Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?Khaled Nashar, Linda F Fried
Postgraduate Medicine|December 9, 2017
Suspected pulmonary embolismGary H Miller, Craig F Fried
Current Opinion in Nephrology and Hypertension|June 15, 2011
Aging and antihypertensive medication-related complications in the chronic kidney disease patientZachary A Marcum, Linda F Fried
The Medical Clinics of North America|May 1, 1997
Hyponatremia and hypernatremiaL F Fried, P M Palevsky
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Kidney International|February 28, 2009
Creatinine and cystatin C: what are the values?Linda F Fried
Kidney International|June 6, 2008
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney diseaseLinda F Fried
Chemotherapy|January 1, 1977
Elimination of para-aminosalicylic acid in patients with liver disease and renal insufficiencyH Held, F Fried
Nephron|July 5, 2018
Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?Srijan Tandukar, Linda F Fried
Clinical Journal of the American Society of Nephrology : CJASN|April 19, 2015
Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con ViewLinda F Fried, Julia Lewis
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 3, 2026
Approach to Hyperkalemia: The Role of Diet and Pharmacological TherapiesAnnabel Biruete, Linda F Fried
Advances in Chronic Kidney Disease|October 24, 2012
Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?Khaled Nashar, Linda F Fried
Postgraduate Medicine|December 9, 2017
Suspected pulmonary embolismGary H Miller, Craig F Fried
Current Opinion in Nephrology and Hypertension|June 15, 2011
Aging and antihypertensive medication-related complications in the chronic kidney disease patientZachary A Marcum, Linda F Fried
The Medical Clinics of North America|May 1, 1997
Hyponatremia and hypernatremiaL F Fried, P M Palevsky
Pageof 16